An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting
Goto, K., Satouchi, M., Ishii, G., Nishio, K., Hagiwara, K., Mitsudomi, T., Whiteley, J., Donald, E., McCormack, R., Todo, T.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer
Yoshioka, H., Shimokawa, M., Seto, T., Morita, S., Yatabe, Y., Okamoto, I., Tsurutani, J., Satouchi, M., Hirashima, T., Atagi, S., Shibata, K., Saito, H., Toyooka, S., Yamamoto, N., Nakagawa, K., Mitsudomi, T.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
Perets, R., Bar, J., Rasco, D.W., Ahn, M.-J., Yoh, K., Kim, D.-W., Nagrial, A., Satouchi, M., Lee, D.H., Spigel, D.R., Kotasek, D., Gutierrez, M., Niu, J., Siddiqi, S., Li, X., Cyrus, J., Chackerian, A., Chain, A., Altura, R.A., Cho, B.C.
Published in Annals of oncology (01.03.2021)
Published in Annals of oncology (01.03.2021)
Get full text
Journal Article
Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study
von Pawel, J., Bordoni, R., Satouchi, M., Fehrenbacher, L., Cobo, M., Han, J.Y., Hida, T., Moro-Sibilot, D., Conkling, P., Gandara, D.R., Rittmeyer, A., Gandhi, M., Yu, W., Matheny, C., Patel, H., Sandler, A., Ballinger, M., Kowanetz, M., Park, K.
Published in European journal of cancer (1990) (01.01.2019)
Published in European journal of cancer (1990) (01.01.2019)
Get full text
Journal Article
Proton and Carbon Ion Radiotherapy for Operable Early-Stage Lung Cancer: 3-Year Results of a Prospective Nationwide Registry
Harada, H., Suefuji, H., Mori, K., Ishikawa, H., Nakamura, M., Tokumaru, S., Murakami, M., Ogino, T., Iwata, H., Tatebe, H., Kubo, N., Waki, T., Yoshida, D., Nakamura, M., Aoyama, H., Araya, M., Nakajima, M., Nakayama, H., Satouchi, M., Shioyama, Y.
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Published in International journal of radiation oncology, biology, physics (01.10.2023)
Get full text
Journal Article
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer
Hotta, K., Hida, T., Nokihara, H., Morise, M., Kim, Y.H., Azuma, K., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Kumagai, T., Watanabe, S., Goto, K., Satouchi, M., Kozuki, T., Shukuya, T., Nakagawa, K., Mitsudomi, T., Yamamoto, N., Asakawa, T., Yoshimoto, T., Takata, S., Tamura, T.
Published in ESMO open (01.08.2022)
Published in ESMO open (01.08.2022)
Get full text
Journal Article
Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS study
Yoshioka, H., Okamoto, I., Morita, S., Ando, M., Takeda, K., Seto, T., Yamamoto, N., Saka, H., Atagi, S., Hirashima, T., Kudoh, S., Satouchi, M., Ikeda, N., Iwamoto, Y., Sawa, T., Nakanishi, Y., Nakagawa, K.
Published in Annals of oncology (01.05.2013)
Published in Annals of oncology (01.05.2013)
Get full text
Journal Article
Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study
Shimokawa, M., Nosaki, K., Seto, T., Ohashi, K., Morise, M., Fujiwara, Y., Sakakibara, J., Murakami, H., Yano, S., Satouchi, M., Matsumoto, S., Goto, K., Yoh, K.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung cancer
Katakami, N., Felip, E., Spigel, D.R., Kim, J.-H., Olivo, M., Guo, M., Nokihara, H., Yang, J. C.-H., Iannotti, N., Satouchi, M., Barlesi, F.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
LURET: Final survival results of the phase II trial of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer
Yoh, K., Seto, T., Satouchi, M., Nishio, M., Yamamoto, N., Murakami, H., Nogami, N., Kuroda, S., Nomura, S., Sato, A., Tsuchihara, K., Kohno, T., Matsumoto, S., Goto, K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Afatinib (AFA) plus bevacizumab (BEV) combination after osimertinib (OSIME) failure for aDvanced EGFR-mutant non-small cell lung cancer (NSCLC): A multicenter prospective single arm phase II study (ABCD-study)
Hata, A., Katakami, N., Nishino, K., Mori, M., Yokoyama, T., Kurata, T., Tachihara, M., Takase, N., Daga, H., Kijima, T., Morita, S., Sakai, K., Nishio, K., Satouchi, M., Negoro, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer
YAMAMOTO, N, MURAKAMI, H, NAKAGAWA, K, HAYASHI, H, FUJISAKA, Y, HIRASHIMA, T, TAKEDA, K, SATOUCHI, M, MIYOSHI, K, AKINAGA, S, TAKAHASHI, T
Published in British journal of cancer (26.11.2013)
Published in British journal of cancer (26.11.2013)
Get full text
Journal Article
Efficacy and Safety of Eribulin Compared with Treatment of Physician’s Choice (TPC) in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study
Spigel, D.R, Barlesi, F, Felip, E, Kim, J, Olivo, M, Nokihara, H, Yang, J.C, Satouchi, M, Katakami, N, Iannotti, N
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies
Ahn, M.J, Tsai, C.M, Yang, J.C.H, Shepherd, F.A, Satouchi, M, Kim, D.W, Bazhenova, L, Hirashima, T, Rukazenkov, Y, Cantarini, M, Mann, H, Ramalingam, S.S, Mitsudomi, T, Jänne, P.A, Goss, G.D
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3043 Clinicopathological features of patients with ROS1-rearranged advanced non-small cell lung cancer: LC-SCRUM-Japan
Sugiyama, E, Matsumoto, S, Yoh, K, Ohe, Y, Seto, T, Murakami, H, Iwama, E, Sugawara, S, Yamada, K, Takeda, K, Hosomi, Y, Saeki, S, Yokoyama, T, Nishio, M, Satouchi, M, Tsuta, K, Kohno, T, Ishii, G, Tsuchihara, K, Goto, K
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3072 Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy
Kasahara, K, Kiura, K, Nogami, N, Takayama, K, Takiguchi, Y, Hirashima, T, Aoe, K, Hayashi, H, Saka, H, Takahashi, K, Imamura, F, Oizumi, S, Inoue, A, Satouchi, M, Tatsumi, M, Nakamura, T, Enatsu, S, Tamura, T, Nakagawa, K
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC)
Sakai, H, Nishio, M, Hida, T, Nakagawa, K, Nogami, N, Atagi, S, Takahashi, T, Nokihara, H, Saka, H, Takenoyama, M, Fujita, S, Tanaka, H, Takeda, K, Satouchi, M, Isobe, H, Maemondo, M, Goto, K, Hirashima, T, Minato, K, Tamura, T
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
PO-0681: Improved prediction of severe radiation pneumonitis by combining V20, VS5, pulmonary fibrosis on CT, and age
Tsujino, K, Hashimoto, T, Shimada, T, Ota, Y, Muraoka, O, Kawaguchi, H, Satouchi, M, Negoro, S, Adachi, S, Soejima, T
Published in Radiotherapy and oncology (2014)
Published in Radiotherapy and oncology (2014)
Get full text
Journal Article
Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib
SATOUCHI, M, NEGORO, S, TAKADA, Y, YATABE, Y, MITSUDOMI, T, FUNADA, Y, URATA, Y, SHIMADA, T, YOSHIMURA, S, KOTANI, Y, SAKUMA, T, WATANABE, H, ADACHI, S
Published in British journal of cancer (23.04.2007)
Published in British journal of cancer (23.04.2007)
Get full text
Journal Article